Agilent, GKIB-302, AdvanceBio InstantAB G0F / FA2 N-glycan Standard

AdvanceBio InstantAB G0F / FA2 N-glycan Standard . N-glycan (asialo-, agalacto-, biantennary, core-substituted with fucose) labeled with InstantAB, for use as a qualitative standard in applications such as liquid chromatography (LC). Alternative glycan names: F(6)A2, NGA2F.

Specifications:
Chemical Structure:
Label: InstantAB
Monoisotopic Mass: MWGlycan + 161.05891 = 1623.6034
Name: G0F
Oxford Name: F(6)A2
Standard Type: Complex-type Native N-Glycan
Unit: 60 pmol

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This reliable N-glycan standard enables precise analysis and quantitation in biopharmaceutical characterization workflows. Featuring a highly purified G0F FA2 glycan derivatized with InstantAB label, the standard supports robust method development, system adjustment, and quality control in glycoprofiling applications. With consistent mass and retention time characteristics, it is ideally suited for users developing or verifying workflows for therapeutic monoclonal antibodies or other glycoproteins. This product is optimized for use with the AdvanceBio Glycan Mapping workflow and offers seamless compatibility with Agilent LC and LC/MS platforms, including UHPLC and HILIC analyses. The labeled glycan enhances detection sensitivity via fluorescence or mass spectrometry, facilitating accurate retention time calibration, peak assignment, and quantitation. Used in combination with additional standards or samples, scientists can confirm system performance, support regulatory compliance in lot release testing, and ensure reliable glycan identification across multiple batches. This standard may be integrated into diverse analytical setups involving Agilent AdvanceBio columns and sample preparation kits. By providing confidence in analytical results, it serves as an essential tool for researchers and quality control analysts engaged in protein characterization, biosimilar comparability, and process monitoring in biopharma development and manufacturing environments.